BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30309313)

  • 1. Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition.
    Cheah ALY; Cheng AC; Spelman D; Nation RL; Kong DCM; McBryde ES
    BMC Infect Dis; 2018 Oct; 18(1):511. PubMed ID: 30309313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.
    Mac S; Fitzpatrick T; Johnstone J; Sander B
    Antimicrob Resist Infect Control; 2019; 8():168. PubMed ID: 31687132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control.
    Reyes K; Bardossy AC; Zervos M
    Infect Dis Clin North Am; 2016 Dec; 30(4):953-965. PubMed ID: 27660091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing an outbreak of vancomycin-resistant enterococci using hidden Markov models.
    McBryde ES; Pettitt AN; Cooper BS; McElwain DL
    J R Soc Interface; 2007 Aug; 4(15):745-54. PubMed ID: 17360254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation.
    Bryce E; Grant J; Scharf S; Dempster L; Lau TT; Laing F; Shajari S; Forrester L
    Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with Vancomycin-resistant Enterococcus acquisition during a large outbreak.
    Fossi Djembi L; Hodille E; Chomat-Jaboulay S; Coudrais S; De Santis N; Gardes S; Mauranne CC; Mourey N; Fredenucci I; Girard R
    J Infect Public Health; 2017; 10(2):185-190. PubMed ID: 27140696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong.
    Cheng VC; Tai JW; Chen JH; So SY; Ng WC; Hung IF; Leung SS; Wong SC; Chan TC; Chan FH; Ho PL; Yuen KY
    J Formos Med Assoc; 2014 Oct; 113(10):734-41. PubMed ID: 24796821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
    Zhou MJ; Li J; Salmasian H; Zachariah P; Yang YX; Freedberg DE
    J Hosp Infect; 2019 Jan; 101(1):69-75. PubMed ID: 30026006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors contributing to vancomycin-resistant Enterococcus spp. horizontal transmission events: exploration of the role of antibacterial consumption.
    Gilbert EM; Zembower TR; Rhodes NJ; Qi C; Reiner S; Malczynski M; Scheetz MH
    Diagn Microbiol Infect Dis; 2017 Sep; 89(1):72-77. PubMed ID: 28669681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Tool for the Prediction of Vancomycin-Resistant Enterococci Colonization Persistence-the PREVENT Score.
    Boeing C; Correa-Martinez CL; Schuler F; Mellmann A; Karch A; Kampmeier S
    Microbiol Spectr; 2021 Oct; 9(2):e0035621. PubMed ID: 34523992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid monitoring of vancomycin-resistant Enterococcus faecium in hospital departments by repetitive element palindromic polymerase chain reaction.
    Froeschen F; Gajdiss M; Uebele J; Meilaender A; Hoerauf A; Exner M; Molitor E; Bierbaum G; Engelhart S; Bekeredjian-Ding I
    J Hosp Infect; 2018 Jun; 99(2):208-217. PubMed ID: 29203445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-resistant enterococci (VRE): transmission and control.
    Tacconelli E; Cataldo MA
    Int J Antimicrob Agents; 2008 Feb; 31(2):99-106. PubMed ID: 18164908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
    Flokas ME; Karageorgos SA; Detsis M; Alevizakos M; Mylonakis E
    Int J Antimicrob Agents; 2017 May; 49(5):565-572. PubMed ID: 28336313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis.
    De Angelis G; Cataldo MA; De Waure C; Venturiello S; La Torre G; Cauda R; Carmeli Y; Tacconelli E
    J Antimicrob Chemother; 2014 May; 69(5):1185-92. PubMed ID: 24458513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units.
    Perencevich EN; Fisman DN; Lipsitch M; Harris AD; Morris JG; Smith DL
    Clin Infect Dis; 2004 Apr; 38(8):1108-15. PubMed ID: 15095215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients.
    Gandra S; Barysauskas CM; Mack DA; Barton B; Finberg R; Ellison RT
    J Hosp Infect; 2014 Nov; 88(3):170-6. PubMed ID: 25441487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci.
    Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
    Clin Infect Dis; 2008 Mar; 46(5):678-85. PubMed ID: 18230044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: Financial burden of screening in a developing country.
    Ulu-Kilic A; Özhan E; Altun D; Perçin D; Güneş T; Alp E
    Am J Infect Control; 2016 Apr; 44(4):e45-9. PubMed ID: 26775930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-Resistant Enterococci (VRE) in The Intensive Care Unit in a Nonoutbreak Setting: Identification of Potential Reservoirs and Epidemiological Associations Between Patient and Environmental VRE.
    McDermott H; Skally M; O'Rourke J; Humphreys H; Fitzgerald-Hughes D
    Infect Control Hosp Epidemiol; 2018 Jan; 39(1):40-45. PubMed ID: 29237512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
    Lee SC; Lee CW; Shih TC; See LC; Chu CM; Liu YC
    J Microbiol Immunol Infect; 2016 Oct; 49(5):749-759. PubMed ID: 27156242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.